APA

Staack R. F., Theobald D. S., Paul L. D., Springer D., Kraemer T. & Maurer H. H. (20040928). In vivo metabolism of the new designer drug 1-(4-methoxyphenyl)piperazine (MeOPP) in rat and identification of the human cytochrome P450 enzymes responsible for the major metabolic step. : Xenobiotica; the fate of foreign compounds in biological systems.

Chicago

Staack R F, Theobald D S, Paul L D, Springer D, Kraemer T and Maurer H H. 20040928. In vivo metabolism of the new designer drug 1-(4-methoxyphenyl)piperazine (MeOPP) in rat and identification of the human cytochrome P450 enzymes responsible for the major metabolic step. : Xenobiotica; the fate of foreign compounds in biological systems.

Harvard

Staack R. F., Theobald D. S., Paul L. D., Springer D., Kraemer T. and Maurer H. H. (20040928). In vivo metabolism of the new designer drug 1-(4-methoxyphenyl)piperazine (MeOPP) in rat and identification of the human cytochrome P450 enzymes responsible for the major metabolic step. : Xenobiotica; the fate of foreign compounds in biological systems.

MLA

Staack R F, Theobald D S, Paul L D, Springer D, Kraemer T and Maurer H H. In vivo metabolism of the new designer drug 1-(4-methoxyphenyl)piperazine (MeOPP) in rat and identification of the human cytochrome P450 enzymes responsible for the major metabolic step. : Xenobiotica; the fate of foreign compounds in biological systems. 20040928.